[1]周星儿 赵施皓 郭宇婷 金荣杰 王继航 王建 郭毅 田进文 沈明志.冠状动脉溶栓在ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2022,(3):229-231,240.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
　ZHOU Xinger,ZHAO Shihao,GUO Yuting,et al.Coronary Thrombolysis in ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(3):229-231,240.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
点击复制

冠状动脉溶栓在ST段抬高型心肌梗死中的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年3期
页码:
229-231,240
栏目:
综述
出版日期:
2022-03-25

文章信息/Info

Title:
Coronary Thrombolysis in ST-Segment Elevation Myocardial Infarction
文章编号:
202111076
作者:
周星儿1; 2 赵施皓1; 2 郭宇婷1; 2 金荣杰1; 2 王继航 1; 2 王建1; 2 郭毅 1; 2 田进文 1; 2 沈明志 1; 2
(1.南方医科大学第二临床医学院,广东 广州 510000;2.解放军总医院海南医院心内科,海南 三亚 572013)
Author(s):
ZHOU Xinger1; 2;  ZHAO Shihao1; 2;  GUO Yuting1; 2;  JIN Rongjie1; 2;  WANG Jihang1; 2;  WANG Jian1; 2;  GUO Yi1; 2;  TIAN Jinwen1; 2;  SHEN Mingzhi1; 2
(1.The Second School of Clinical Medicine,Sourthen Medical University,Guangzhou 510000,Guangdong,China; 2. Department of Cardiology,Hainan Hospital of PLA General Hospital,Sanya 572013,Hainan,China)
关键词:
ST段抬高型心肌梗死; 心肌再灌注; 溶栓剂; 冠状动脉内溶栓
Keywords:
ST-segment elevation myocardial infarction; Myocardial reperfusion; Thrombolytic agents; Intracoronary thrombolysis
DOI:
10.16806/j.cnki.issn.1004-3934.2022.03.000
摘要:
ST段抬高型心肌梗死是常见的心血管急危重症，致死率和致残率高。尽早实现心肌再灌注可有效挽救濒死心肌，改善ST段抬高型心肌梗死患者的预后，冠状动脉内溶栓在实现再灌注过程中发挥重要作用。现从血栓形成的机制、溶栓剂分类，冠状动脉内正向溶栓、血栓抽吸、血栓抽吸联合冠状动脉内溶栓、冠状动脉内逆向溶栓及应用前景等方面展开综述。
Abstract:
ST-segment elevation myocardial infarction is a common emergen t and critical cardiovascular disease with high mortality and disability rate. Early myocardial reperfusion can effectively save the dying myocardium and improve the prognosis of patients with ST-segment elevation myocardial infarction. Intracoronary thrombolysis plays an important role in the process of reperfusion. This article reviews the mechanisms of thrombogenesis,the classification of thrombolytic agents,intracoronary forward thrombolysis,thrombus aspiration,thrombus aspiration combined with intracoronary thrombolysis,intracoronary retrograde thrombolysis and its application prospect

参考文献/References:

[1] Tian JW,Zhu M,Wang FQ,et al. Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention:a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction[J]. J Geriatr Cardiol,2019,16(6):458-467.

[2] 庞兴学,王显. 血栓形成的过程与机制研究进展[J]. 医学综述,2011,17(11):1613-1616.

[3] Ali MR,Salim HM,Islam MA,et al. Aspect of thrombolytic therapy:a review[J]. ScientificWorldJournal,2014,2014:586510.

[4] Maznyczka AM,Mccartney P,Duklas P,et al. Effect of coronary flow on intracoronary alteplase:a prespecified analysis from a randomised trial[J].Heart,2021,Jan12;heartjnl-2020-317828.DOI:10.1136/heartjnl-2020-317828.?Online ahead of print.

[5] Mccartney PJ,Maznyczka AM,Eteiba H,et al. Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time[J]. J Am Coll Cardiol,2020,75(12):1406-1421.

[6] Huang D,Qian J,Liu Z,et al. Effects of intracoronary pro-urokinase or tirofiban on coronary flow during primary percutaneous coronary intervention for acute myocardial infarction:a multi-center,placebo-controlled,single-blind,randomized clinical trial[J]. Front Cardiovasc Med,2021,8:710994.

[7] 赵亚红,邱祥春. 急性ST段抬高型心肌梗死溶栓药物进展[J]. 内蒙古民族大学学报(自然科学版),2017,32(2):166-169.

[8] Fu Y,Gu XS,Hao GZ,et al. Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2019,93(S1):839-845.

[9] Jayagopal PB,Sarjun Basha KM. Intracoronary tenecteplase in STEMI with massive thrombus[J]. Indian Heart J,2018,70(3):446-449.

[10] Geng W,Zhang Q,Liu J,et al. A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction[J]. J Interv Cardiol,2018,31(2):136-143.

[11] Maznyczka AM,Mccartney PJ,Oldroyd KG,et al. Effects of intracoronary alteplase on microvascular function in acute myocardial infarction[J]. J Am Heart Assoc,2020,9(3):e14066.

[12] Alyamani M,Campbell S,Navarese E,et al. Safety and efficacy of intracoronary thrombolysis as adjunctive therapy to primary PCI in STEMI:a systematic review and meta-analysis[J]. Can J Cardiol,2021,37(2):339-346.

[13] Burzotta F,Trani C,Romagnoli E,et al. Manual thrombus-aspiration improves myocardial reperfusion:the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty(REMEDIA) trial[J]. J Am Coll Cardiol,2005,46(2):371-376.

[14] 陈玉善,关怀敏,解金红,等. 不同治疗方法在急性ST段抬高型心肌梗死患者急诊冠状动脉介入术中的疗效观察[J]. 中国医师进修杂志,2014,37(22):1-4.

[15] Boscarelli D,Vaquerizo B,Miranda-Guardiola F,et al. Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration[J]. Eur Heart J Acute Cardiovasc Care,2014,3(3):229-236.

[16] Scarpone M,Cenko E,Manfrini O. Coronary no-reflow phenomenon in clinical practice[J]. Curr Pharm Des,2018,24(25):2927-2933.

[17] Levine GN,Bates ER,Blankenship JC,et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction:an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction[J]. J Am Coll Cardiol,2016,67(10):1235-1250.

[18] Lee Y,Kim E,Kim BK,et al. A case of successful reperfusion through a combination of intracoronary thrombolysis and aspiration thrombectomy in ST-segment elevation myocardial infarction associated with an ectatic coronary artery[J]. BMC Cardiovasc Disord,2017,17(1):94.

[19] Wang X,Liu H,Wu H,et al. Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden[J]. Coron Artery Dis,2020,31(6):493-499.

[20] Lagerqvist B,Fr?bert O,Olivecrona GK,et al. Outcomes 1 year after thrombus aspiration for myocardial infarction[J]. N Engl J Med,2014,371(12):1111-1120.

[21] Jolly SS,Cairns JA,Yusuf S,et al. Randomized trial of primary PCI with or without routine manual thrombectomy[J]. N Engl J Med,2015,372(15):1389-1398.

[22] Secemsky EA,Ferro EG,Rao SV,et al. Association of physician variation in use of manual aspiration thrombectomy with outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction:the national cardiovascular data registry CathPCI registry[J]. JAMA Cardiol,2019,4(2):110-118.

[23] 田进文,彭利,刘谟焓,等. 逆向精确溶栓联合支架植入术治疗急性冠状动脉闭塞病变1例[J]. 中华老年多器官疾病杂志,2013(8):633-635.

[24] 农京国,白静,彭亮,等. 冠状动脉内逆向溶栓在急性ST段抬高型心肌梗死患者直接介入治疗术后1年随访[J]. 中华老年心脑血管病杂志,2016,18(9):905-908.

[25] Xiao Y,Fu X,Wang Y,et al. Effects of different strategies on high thrombus burden in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary catheterization[J]. Coron Artery Dis,2019,30(8):555-563.

[26] 郭自同,沈鑫,王钊,等. 逆向溶栓联合PCI术对急性ST段抬高型心肌梗死的疗效观察[J]. 中国急救医学,2017,37(5):454-457.

[27] 史习良,刘刚,陈佳男. 逆向溶栓联合经皮冠脉介入治疗对STEMI患者近期左心功能及远期预后的影响[J]. 现代实用医学,2020,32(1):23-25.

[28] Wang Y,Zhao HW,Wang CF,et al. Incidence,predictors,and prognosis of coronary slow-flow and no-reflow phenomenon in patients with chronic total occlusion who underwent percutaneous coronary intervention[J]. Ther Clin Risk Manag,2020,16:95-101.

[29] Pantea-Ro?an LR,Pantea VA,Bungau S,et al. No-reflow after PPCI—A predictor of short-term outcomes in STEMI patients[J]. J Clin Med,2020,9(9):2956.

[30] Sezer M,Cimen A,Aslanger E,et al. Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size,volumes,and function[J]. J Am Coll Cardiol,2009,54(12):1065-1071.

相似文献/References:

[1]刘丹丹 王海珠 任凤波.ST段抬高型心肌梗死PCI术后血浆微囊泡浓度对再次血运重建的风险预测分析[J].心血管病学进展,2019,(7):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
　LIU Dandan,WANG Haizhu,REN Fengbo.Predictive analysis of plasma microvesicles concentration in patients with ST-segment elevation myocardial infarction after target lesion revascularization[J].Advances in Cardiovascular Diseases,2019,(3):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
[2]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
　HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(3):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[3]金荣杰 徐勇 邓珏琳 沈明志.应用心脏磁共振评估前列地尔对ST段抬高型心肌梗死患者心肌灌注的影响[J].心血管病学进展,2020,(10):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
　JIN RongjieXU YongDENG JuelinSHEN Mingzhi.Effect of Alprostadil on Myocardial Perfusion of Patients with ST Segment Elevation Myocardial Infarction Directly Receiving Percutaneous Coronary Intervention Assessed with Cardiac Magnetic Resonance[J].Advances in Cardiovascular Diseases,2020,(3):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
[4]宋艳华 来春林 杨五小.急性 ST段抬高型心肌梗死患者微血管功能障碍的研究进展[J].心血管病学进展,2022,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
　SONG Yanhua,LAI Chunlin,YANG Wuxiao.Microvascular Dysfunction in Patients with Acute ST-Segment?levation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(3):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]

更新日期/Last Update: 2022-04-20